This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Centre National De La Recherche Scientifique. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Denyse Herlem: Innovator in Cancer Treatment
Introduction
Denyse Herlem is a prominent inventor based in Versailles, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of pyranone derivatives. Her work is recognized for its potential therapeutic applications in combating cancer.
Latest Patents
Denyse Herlem holds a patent for "Pyranone derivatives useful for treating cancer." This invention relates to pyranone derivatives of general formula (I), wherein X is chlorine, bromine, or iodine, and R and R' are independently a hydrogen atom, an alkyl, cycloalkyl, or alkylene group containing 1-20 carbon atoms. These groups may be optionally substituted by a hydroxyl, amino, ether, or halogen group. Additionally, R and R' can form a cycle of 5, 6, 7, or 8 members, which is also optionally substituted. The patent includes methods for preparing these derivatives and their therapeutic use, particularly in treating cancer.
Career Highlights
Denyse Herlem is affiliated with the Centre National de la Recherche Scientifique, where she conducts her research. Her dedication to advancing cancer treatment through innovative solutions has positioned her as a key figure in her field.
Collaborations
Denyse collaborates with notable colleagues, including Guy Jean Marie Potier, who serves as the Legal Representative, and Jérôme Bignon. Their combined expertise contributes to the success of her research initiatives.
Conclusion
Denyse Herlem's work in developing pyranone derivatives showcases her commitment to innovation in cancer treatment. Her contributions are vital in the ongoing fight against this disease, and her collaborations further enhance the impact of her research.